As of 3:52pm ET
| +0.89 / +5.99%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 22.00, with a high estimate of 33.00 and a low estimate of 22.00. The median estimate represents a +39.77% increase from the last price of 15.74.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.